Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
Cystic fibrosis transmembrane conductance regulator (CFTR) adenosine triphosphate-dependent chloride channels are expressed in epithelial cells and are associated with a number of genetic disorders, including cystic fibrosis. Venom of the scorpion Leirus quinquestriatus hebraeus reversibly inhibits CFTR when applied to its cytoplasmic surface. To examine the state-dependence of inhibition we recorded wild-type and mutant CFTR channel currents using inside-out membrane patches from Xenopus oocytes. Application of either venom or diphenylamine-2-carboxylate to channels that were either activated (open) or resting (closed) indicate primarily closed state-dependent inhibition of CFTR by venom, whereas diphenylamine-2-carboxylate showed no state-dependence of block. Efficacy of venom-mediated macroscopic current inhibition was inversely related to channel activity. Analysis of single-channel and macropatch data indicated that venom could either inhibit channel opening, if it binds during an interburst closed state or in the absence of cytosolic adenosine triphosphate, or introduce new intraburst closed states, if it binds during an open event. The on-rate of venom binding for intraburst block could be modulated by changing CFTR activity with vanadate or adenylyl-imidodiphosphate, or by introducing the Walker A mutation K1250A. These findings represent the first description of state-dependent inhibition of CFTR and suggest that the active toxin could be used as a tool to study the conformational changes that occur during CFTR gating.
Accardi,
Conformational changes in the pore of CLC-0.
2003, Pubmed,
Xenbase
Accardi,
Conformational changes in the pore of CLC-0.
2003,
Pubmed
,
Xenbase
Al-Nakkash,
Activation of wild-type and deltaF508-CFTR by phosphodiesterase inhibitors through cAMP-dependent and -independent mechanisms.
1999,
Pubmed
Basso,
Prolonged nonhydrolytic interaction of nucleotide with CFTR's NH2-terminal nucleotide binding domain and its role in channel gating.
2003,
Pubmed
,
Xenbase
Baukrowitz,
Coupling of CFTR Cl- channel gating to an ATP hydrolysis cycle.
1994,
Pubmed
Carson,
The two nucleotide-binding domains of cystic fibrosis transmembrane conductance regulator (CFTR) have distinct functions in controlling channel activity.
1995,
Pubmed
Chang,
Structure of MsbA from E. coli: a homolog of the multidrug resistance ATP binding cassette (ABC) transporters.
2001,
Pubmed
Chen,
CFTR is a monomer: biochemical and functional evidence.
2002,
Pubmed
Chen,
Pore- and state-dependent cadmium block of I(Ks) channels formed with MinK-55C and wild-type KCNQ1 subunits.
2003,
Pubmed
,
Xenbase
Cheng,
Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis.
1990,
Pubmed
Csanády,
Severed channels probe regulation of gating of cystic fibrosis transmembrane conductance regulator by its cytoplasmic domains.
2000,
Pubmed
,
Xenbase
Devuyst,
Chloride channels in the kidney: lessons learned from knockout animals.
2002,
Pubmed
Fuller,
Inhibition of CFTR channels by a peptide toxin of scorpion venom.
2004,
Pubmed
,
Xenbase
Gadsby,
Control of CFTR channel gating by phosphorylation and nucleotide hydrolysis.
1999,
Pubmed
Hung,
Crystal structure of the ATP-binding subunit of an ABC transporter.
1998,
Pubmed
Hwang,
Regulation of the gating of cystic fibrosis transmembrane conductance regulator C1 channels by phosphorylation and ATP hydrolysis.
1994,
Pubmed
Ikuma,
Regulation of CFTR Cl- channel gating by ATP binding and hydrolysis.
2000,
Pubmed
Ishihara,
Block by MOPS reveals a conformation change in the CFTR pore produced by ATP hydrolysis.
1997,
Pubmed
Kidd,
A heteromeric complex of the two nucleotide binding domains of cystic fibrosis transmembrane conductance regulator (CFTR) mediates ATPase activity.
2004,
Pubmed
Lansdell,
Two mechanisms of genistein inhibition of cystic fibrosis transmembrane conductance regulator Cl- channels expressed in murine cell line.
2000,
Pubmed
McCarty,
Permeation through the CFTR chloride channel.
2000,
Pubmed
McCarty,
Voltage-dependent block of the cystic fibrosis transmembrane conductance regulator Cl- channel by two closely related arylaminobenzoates.
1993,
Pubmed
,
Xenbase
McDonough,
Novel pore-lining residues in CFTR that govern permeation and open-channel block.
1994,
Pubmed
Milnes,
Preferential closed channel blockade of HERG potassium currents by chemically synthesised BeKm-1 scorpion toxin.
2003,
Pubmed
Muanprasat,
Discovery of glycine hydrazide pore-occluding CFTR inhibitors: mechanism, structure-activity analysis, and in vivo efficacy.
2004,
Pubmed
Naranjo,
Inhibition of single Shaker K channels by kappa-conotoxin-PVIIA.
2002,
Pubmed
,
Xenbase
Quinton,
Cystic fibrosis: a disease in electrolyte transport.
1990,
Pubmed
Reyes,
Structure of the ABC transporter MsbA in complex with ADP.vanadate and lipopolysaccharide.
2005,
Pubmed
Riordan,
Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.
1989,
Pubmed
Rosenberg,
Purification and crystallization of the cystic fibrosis transmembrane conductance regulator (CFTR).
2004,
Pubmed
Schultz,
Pharmacology of CFTR chloride channel activity.
1999,
Pubmed
Seibert,
Cytoplasmic loop three of cystic fibrosis transmembrane conductance regulator contributes to regulation of chloride channel activity.
1996,
Pubmed
Sheppard,
Structure and function of the CFTR chloride channel.
1999,
Pubmed
Smit,
Functional roles of the nucleotide-binding folds in the activation of the cystic fibrosis transmembrane conductance regulator.
1993,
Pubmed
,
Xenbase
Stocker,
Preferential interaction of omega-conotoxins with inactivated N-type Ca2+ channels.
1997,
Pubmed
,
Xenbase
Taddei,
Altered channel gating mechanism for CFTR inhibition by a high-affinity thiazolidinone blocker.
2004,
Pubmed
Terlau,
The block of Shaker K+ channels by kappa-conotoxin PVIIA is state dependent.
1999,
Pubmed
,
Xenbase
Vergani,
CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains.
2005,
Pubmed
Vergani,
On the mechanism of MgATP-dependent gating of CFTR Cl- channels.
2003,
Pubmed
,
Xenbase
Wang,
Actions of genistein on cystic fibrosis transmembrane conductance regulator channel gating. Evidence for two binding sites with opposite effects.
1998,
Pubmed
Winter,
Effect of ATP concentration on CFTR Cl- channels: a kinetic analysis of channel regulation.
1994,
Pubmed
Yang,
Inhibition of Na(+) current by imipramine and related compounds: different binding kinetics as an inactivation stabilizer and as an open channel blocker.
2002,
Pubmed
Zeltwanger,
Gating of cystic fibrosis transmembrane conductance regulator chloride channels by adenosine triphosphate hydrolysis. Quantitative analysis of a cyclic gating scheme.
1999,
Pubmed
Zhang,
Determination of the functional unit of the cystic fibrosis transmembrane conductance regulator chloride channel. One polypeptide forms one pore.
2005,
Pubmed
Zhang,
Direct comparison of NPPB and DPC as probes of CFTR expressed in Xenopus oocytes.
2000,
Pubmed
,
Xenbase
Zhang,
Steady-state interactions of glibenclamide with CFTR: evidence for multiple sites in the pore.
2004,
Pubmed
,
Xenbase
